Join our email list to stay up to date on the latest Amyloidosis news.

The 2nd European Congress for ATTR Amyloidosis, for doctors and patients, aims to bring the needs and accomplishments for patients together. Potent drugs recently entered the market to treat patients with ATTR variants. More therapies are anticipated in the near future. This meeting will give the opportunity to exchange needs and knowledge in this interdisciplinary field of medicine.

*

*

*









*